Effects of a support group leader education program jointly developed by health professionals and patients on peer leader self-efficacy among leaders of scleroderma support groups: a two-arm parallel partially nested randomised controlled trial

Simple item page
dc.contributor.authorThombs, Brett D.
dc.contributor.authorLevis, Brooke
dc.contributor.authorCarrier, Marie-Eve
dc.contributor.authorDyas, Laura
dc.contributor.authorNordlund, Julia
dc.contributor.authorTao, Lydia
dc.contributor.authorAguila, Kylene
dc.contributor.authorBourgeault, Angelica
dc.contributor.authorKonrad, Violet
dc.contributor.authorSauvé, Maureen
dc.contributor.authorConnolly, Kerri
dc.contributor.authorHenry, Richard S.
dc.contributor.authorØstbø, Nora
dc.contributor.authorLevis, Alexander W.
dc.contributor.authorKwakkenbos, Linda
dc.contributor.authorMalcarne, Vanessa L.
dc.contributor.authorEl-Baalbaki, Ghassan
dc.contributor.authorHudson, Marie
dc.contributor.authorWurz, Amanda
dc.contributor.authorCulos-Reed, S. N.
dc.contributor.authorPlatt, Robert W.
dc.contributor.authorBenedetti, Andrea
dc.date.accessioned2022-10-30T00:02:26Z
dc.date.available2022-10-30T00:02:26Z
dc.date.issued2022-10-28
dc.date.updated2022-10-30T00:02:26Z
dc.description.abstractAbstract Background More people with rare diseases likely receive disease education and emotional and practical support from peer-led support groups than any other way. Most rare-disease support groups are delivered outside of the health care system by untrained leaders. Potential benefits may not be achieved and harms, such as dissemination of inaccurate information, may occur. Our primary objective was to evaluate the effects of a rare-disease support group leader education program, which was developed collaboratively by researchers, peer support group leaders, and patient organization leaders, compared to waitlist control, on peer leader self-efficacy among scleroderma support group leaders. Methods The trial was a pragmatic, two-arm partially nested randomised controlled trial with 1:1 allocation into intervention or waitlist control. Eligible participants were existing or candidate peer support group leaders affiliated with a scleroderma patient organization. Leader training was delivered in groups of 5–6 participants weekly for 13 weeks in 60–90 min sessions via the GoToMeeting® videoconferencing platform. The program included 12 general leader training modules and one module specific to scleroderma. Primary outcome was leader self-efficacy, measured by the Support Group Leader Self-efficacy Scale (SGLSS) immediately post-intervention. Secondary outcomes were leader self-efficacy 3 months post-intervention; emotional distress, leader burnout, and volunteer satisfaction post-intervention and 3 months post-intervention; and program satisfaction among intervention participants post-intervention. Results One hundred forty-eight participants were randomised to intervention (N = 74) or waitlist (N = 74). Primary outcome data were provided by 146 (99%) participants. Mean number of sessions attended was 11.4 (standard deviation = 2.6). Mean program satisfaction score (CSQ-8) was 30.3 (standard deviation = 3.0; possible range 8–32). Compared to waitlist control, leader self-efficacy was higher post-intervention [SGLSS; 16.7 points, 95% CI 11.0–22.3; standardized mean difference (SMD) 0.84] and 3 months later (15.6 points, 95% CI 10.2–21.0; SMD 0.73); leader volunteer satisfaction was significantly higher at both assessments, emotional distress was lower post-intervention but not 3 months later, and leader burnout was not significantly different at either assessment. Conclusions Peer support group leader education improved leader self-efficacy substantially. The program could be easily adapted for support group leaders in other rare diseases. Trial registration: NCT03965780 ; registered on May 29, 2019.
dc.identifier.citationOrphanet Journal of Rare Diseases. 2022 Oct 28;17(1):396
dc.identifier.doihttps://doi.org/10.1186/s13023-022-02552-x
dc.identifier.urihttp://hdl.handle.net/1880/115391
dc.identifier.urihttps://doi.org/10.11575/PRISM/45556
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dc.titleEffects of a support group leader education program jointly developed by health professionals and patients on peer leader self-efficacy among leaders of scleroderma support groups: a two-arm parallel partially nested randomised controlled trial
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
13023_2022_Article_2552.pdf
Size:
1.2 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Publications